Schizophrenia is a complex and debilitating neurodevelopmental syndrome with devastating costs to patients, families, and societies. It is a clinically heterogeneous disorder characterized by diverse psychopathologic processes, including cognitive impairment and positive and negative symptoms.
1 There is significantly increased risk of premature mortality in individuals with schizophrenia, with mean reduction in life expectancy for women of 11.39 (95% CI, 11.06-11.73) years and for men of 13.48 (95% CI, 13.21-13.77) years.
2 The worldwide prevalence of schizophrenia approaches 1% with an incidence rate of approximately 1.5 per 10 000 individuals annually.
3,4 Although both genetic and environmental risk factors influence risk of schizophrenia,
5-7 the underlying etiology remains poorly understood.